These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23913386)

  • 1. Polymorphisms of the angiotensin II type 1 receptor gene affect antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.
    Gong HT; Ma XL; Chen BX; Xu XY; Li Q; Guo CX; Du FH
    Genet Mol Res; 2013 Jun; 12(2):2068-75. PubMed ID: 23913386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients.
    Aoki A; Ogawa T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Nitta K
    Heart Vessels; 2010 May; 25(3):195-202. PubMed ID: 20512446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.
    Gong HT; Mu LY; Zhang T; Xu XY; Du FH
    J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827205. PubMed ID: 30798697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
    Cicero AF; Veronesi M; Prandin MG; Di Gregori V; Ambrosioni E; Borghi C
    Fundam Clin Pharmacol; 2009 Oct; 23(5):583-8. PubMed ID: 19555395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.
    Redon J; Luque-Otero M; Martell N; Chaves FJ;
    Pharmacogenomics J; 2005; 5(1):14-20. PubMed ID: 15505642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphisms of
    Gong H; Mu L; Zhang T; Xu X; Du F
    J Genet; 2019 Mar; 98():. PubMed ID: 30945668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE; Lins LE; Hermansson K
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.
    Kurland L; Hallberg P; Melhus H; Liljedahl U; Hashemi N; Syvänen AC; Lind L; Kahan T
    Am J Hypertens; 2008 Jul; 21(7):836-9. PubMed ID: 18464745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.
    Mallion J; Siche J; Lacourcière Y
    J Hum Hypertens; 1999 Oct; 13(10):657-64. PubMed ID: 10516734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
    Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
    Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan: a review of its use in hypertension.
    Sharpe M; Jarvis B; Goa KL
    Drugs; 2001; 61(10):1501-29. PubMed ID: 11558835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment plasma renin activity levels correlate with the blood pressure response to telmisartan in essential hypertension.
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Jan; 21(1):10-3. PubMed ID: 18091737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension.
    Shiga Y; Miura S; Mitsutake R; Norimatsu K; Nagata I; Arimura T; Shimizu T; Morii J; Kuwano T; Uehara Y; Inoue A; Shirotani T; Fujisawa K; Matsunaga E; Saku K
    J Renin Angiotensin Aldosterone Syst; 2012 Sep; 13(3):394-400. PubMed ID: 22427308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of telmisartan for blood pressure reduction among angiotensin II receptor blockers: a meta-analysis of head-to-head randomized trials.
    Takagi H; Mizuno Y; Goto SN; Umemoto T;
    Int J Cardiol; 2013 Sep; 167(6):3051-6. PubMed ID: 23219133
    [No Abstract]   [Full Text] [Related]  

  • 18. The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
    Vogt L; Navis G; Köster J; Manolis AJ; Reid JL; de Zeeuw D;
    J Hypertens; 2005 Nov; 23(11):2055-61. PubMed ID: 16208149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements.
    Weber MA; White WB; Giles TD; Bakris GL; Neutel JM; Smith DH; Davidai G
    J Clin Hypertens (Greenwich); 2006 Apr; 8(4):241-50; quiz 251-2. PubMed ID: 16596026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan in patients with mild/moderate hypertension and chronic kidney disease.
    Sharma AM; Hollander A; Köster J; ;
    Clin Nephrol; 2005 Apr; 63(4):250-7. PubMed ID: 15847251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.